MRSA meningitis and intrathecal injection of arbekacin.
Fujita
T
T
Department of Surgical Neurology, Yamagata University School of Medicine, Japan.
Kayama
T
T
Sato
I
I
Fukai
H
H
Sobue
H
H
Nakai
O
O
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D003982:Dibekacin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007278:Injections, Spinal; D016920:Meningitis, Bacterial / Q000188:drug therapy* / Q000382:microbiology*; D016106:Methicillin Resistance; D008875:Middle Aged; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000382:microbiology; D013211:Staphylococcus aureus / Q000187:drug effects
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D003982:Dibekacin; C031986:arbekacin